LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 1 | H04 | 72 | hr | 1476 | 3580 | 3694 | 0.9691 | 0.9486 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 2 | H04 | 72 | hr | 1476 | 3478 | 3694 | 0.9415 | 0.9026 |
| SK-BR-3 | Nintedanib | 0.37 | uM | LJP6 | 3 | H04 | 72 | hr | 1476 | 3669 | 3694 | 0.9932 | 0.9887 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 1 | C10 | 72 | hr | 1476 | 3254 | 3694 | 0.8809 | 0.8015 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 2 | C10 | 72 | hr | 1476 | 3320 | 3694 | 0.8987 | 0.8313 |
| SK-BR-3 | NU7441 | 0.37 | uM | LJP5 | 3 | C10 | 72 | hr | 1476 | 3391 | 3694 | 0.9180 | 0.8633 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 1 | M16 | 72 | hr | 1476 | 1583 | 3694 | 0.4285 | 0.0479 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 2 | M16 | 72 | hr | 1476 | 1553 | 3694 | 0.4204 | 0.0344 |
| SK-BR-3 | Dactolisib | 0.37 | uM | LJP5 | 3 | M16 | 72 | hr | 1476 | 1753 | 3694 | 0.4746 | 0.1246 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 1 | K16 | 72 | hr | 1476 | 3231 | 3694 | 0.8747 | 0.7912 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 2 | K16 | 72 | hr | 1476 | 3505 | 3694 | 0.9488 | 0.9147 |
| SK-BR-3 | NVP-TAE684 | 0.37 | uM | LJP6 | 3 | K16 | 72 | hr | 1476 | 3194 | 3694 | 0.8646 | 0.7745 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1476 | 2937 | 3694 | 0.7951 | 0.6586 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1476 | 2804 | 3694 | 0.7591 | 0.5986 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1476 | 2841 | 3694 | 0.7691 | 0.6153 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 1 | C04 | 72 | hr | 1476 | 3317 | 3694 | 0.8979 | 0.8300 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 2 | C04 | 72 | hr | 1476 | 3615 | 3694 | 0.9786 | 0.9644 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP5 | 3 | C04 | 72 | hr | 1476 | 3619 | 3694 | 0.9797 | 0.9662 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 1 | E04 | 72 | hr | 1476 | 3450 | 3694 | 0.9339 | 0.8899 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 2 | E04 | 72 | hr | 1476 | 3599 | 3694 | 0.9743 | 0.9571 |
| SK-BR-3 | PD0325901 | 0.37 | uM | LJP6 | 3 | E04 | 72 | hr | 1476 | 3602 | 3694 | 0.9751 | 0.9585 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 1476 | 4059 | 3694 | 1.0988 | 1.1646 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 1476 | 4040 | 3694 | 1.0937 | 1.1560 |
| SK-BR-3 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 1476 | 4088 | 3694 | 1.1066 | 1.1777 |
| SK-BR-3 | PD184352 | 0.37 | uM | LJP5 | 1 | L10 | 72 | hr | 1476 | 3579 | 3694 | 0.9689 | 0.9481 |